Geneos Wealth Management Inc.
Position in AVXL — Anavex Life Sciences Corp.
CIK 1764754
ENGLEWOOD, CO
Position in AVXL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$149,202
-$22,390 QoQ
Shares Held
48,600
+0.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Geneos Wealth Management Inc. holds $2,712,041 across 32 Biotechnology names. AVXL ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
12,399 | $801,347 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
240,927 | $672,186 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
835 | $645,154 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
This page
|
48,600 | $149,202 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
2,169 | $72,054 | |
| 6 | INSM |
INSMED Inc
|
414 | $67,697 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $45,100 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
5,754 | $44,133 |
All Filings in AVXL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,202 | 48,600 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $171,592 | 48,200 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $377,360 | 42,400 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $415,361 | 45,050 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $385,671 | 44,950 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $577,543 | 53,775 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $387,518 | 68,225 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $378,639 | 89,725 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $378,696 | 74,400 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $629,356 | 67,600 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $275,755 | 42,100 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $342,273 | 42,100 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $360,797 | 42,100 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $371,326 | 40,100 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $345,720 | 33,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $388,388 | 38,800 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $389,611 | 31,650 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $389,283 | 22,450 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $402,977 | 22,450 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $491,490 | 21,500 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $381,225 | 25,500 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $132,300 | 24,500 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $109,200 | 24,000 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $68,880 | 14,000 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $44,100 | 14,000 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||